Infliximab in extrapulmonary sarcoidosis: tantalising but inconclusive.
A U
AU
Wells
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006801:Humans; D000069285:Infliximab; D012507:Sarcoidosis / Q000188:drug therapy*; D015983:Selection Bias
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab